120 related articles for article (PubMed ID: 38182567)
21. De novo loss-of-function variants of ASH1L are associated with an emergent neurodevelopmental disorder.
Shen W; Krautscheid P; Rutz AM; Bayrak-Toydemir P; Dugan SL
Eur J Med Genet; 2019 Jan; 62(1):55-60. PubMed ID: 29753921
[TBL] [Abstract][Full Text] [Related]
22. Phenotypes of a female patient with novel de novo frameshift ARX variant identified by whole-exome sequencing: a case report.
Iskandar K; Herini ES; Triono A; Hadiyanto ML; Nugrahanto AP; Gunadi
Ann Med Surg (Lond); 2023 Feb; 85(2):236-241. PubMed ID: 36845779
[TBL] [Abstract][Full Text] [Related]
23. Chorioamnionitis and risk of long-term neurodevelopmental disorders in offspring: a population-based cohort study.
Tsamantioti E; Lisonkova S; Muraca G; Örtqvist AK; Razaz N
Am J Obstet Gynecol; 2022 Aug; 227(2):287.e1-287.e17. PubMed ID: 35305960
[TBL] [Abstract][Full Text] [Related]
24. A de novo CSDE1 variant causing neurodevelopmental delay, intellectual disability, neurologic and psychiatric symptoms in a child of consanguineous parents.
Gangfuß A; Lochmüller H; Töpf A; O'Heir E; Horvath R; Kölbel H; Schweiger B; Schara-Schmidt U; Roos A
Am J Med Genet A; 2022 Jan; 188(1):283-291. PubMed ID: 34519148
[TBL] [Abstract][Full Text] [Related]
25. A de novo frameshift pathogenic variant in TBR1 identified in autism without intellectual disability.
Sapey-Triomphe LA; Reversat J; Lesca G; Chatron N; Bussa M; Mazoyer S; Schmitz C; Sonié S; Edery P
Hum Genomics; 2020 Sep; 14(1):32. PubMed ID: 32948248
[TBL] [Abstract][Full Text] [Related]
26. A de novo PAK1 likely pathogenic variant and a de novo terminal 1q microdeletion in a Chinese girl with global developmental delay, severe intellectual disability, and seizures.
Zhuang J; Xie M; Yao J; Fu W; Zeng S; Jiang Y; Wang Y; Xie Y; Wang G; Chen C
BMC Med Genomics; 2023 Jan; 16(1):3. PubMed ID: 36624491
[TBL] [Abstract][Full Text] [Related]
27. A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.
Qiao F; Wang C; Luo C; Wang Y; Shao B; Tan J; Hu P; Xu Z
Mol Genet Genomic Med; 2019 Sep; 7(9):e897. PubMed ID: 31347296
[TBL] [Abstract][Full Text] [Related]
28. Novel Synonymous and Frameshift Variants in the
Yi S; Chen F; Qin Z; Yi S; Huang L; Huang L; Feng Y; Wei H; Yang Q; Zhang Q; Luo J
Neurol Genet; 2022 Dec; 8(6):e200025. PubMed ID: 36275919
[TBL] [Abstract][Full Text] [Related]
29. Neural correlates of shared sensory symptoms in autism and attention-deficit/hyperactivity disorder.
Itahashi T; Fujino J; Sato T; Ohta H; Nakamura M; Kato N; Hashimoto RI; Di Martino A; Aoki YY
Brain Commun; 2020; 2(2):fcaa186. PubMed ID: 33381756
[TBL] [Abstract][Full Text] [Related]
30. Delayed autism spectrum disorder recognition in children and adolescents previously diagnosed with attention-deficit/hyperactivity disorder.
Kentrou V; de Veld DM; Mataw KJ; Begeer S
Autism; 2019 May; 23(4):1065-1072. PubMed ID: 30244604
[TBL] [Abstract][Full Text] [Related]
31. Neurodevelopmental disorders and incontinence in children and adolescents: Attention-deficit/hyperactivity disorder, autism spectrum disorder, and intellectual disability-A consensus document of the International Children's Continence Society.
von Gontard A; Hussong J; Yang SS; Chase J; Franco I; Wright A
Neurourol Urodyn; 2022 Jan; 41(1):102-114. PubMed ID: 34586694
[TBL] [Abstract][Full Text] [Related]
32. Trio exome sequencing identified a novel de novo WASF1 missense variant leading to recurrent site substitution in a Chinese patient with developmental delay, microcephaly, and early-onset seizures: A mutational hotspot p.Trp161 and literature review.
Zhao A; Zhou R; Gu Q; Liu M; Zhang B; Huang J; Yang B; Yao R; Wang J; Lv H; Wang J; Shen Y; Wang H; Chen X
Clin Chim Acta; 2021 Dec; 523():10-18. PubMed ID: 34478686
[TBL] [Abstract][Full Text] [Related]
33. [Intellectual developmental disability overlapping with autism spectrum disorder and attention deficit-hyperactivity disorder].
Mulas F; Rojas M
Medicina (B Aires); 2018; 78 Suppl 2():63-68. PubMed ID: 30199368
[TBL] [Abstract][Full Text] [Related]
34. Disruption of RFX family transcription factors causes autism, attention-deficit/hyperactivity disorder, intellectual disability, and dysregulated behavior.
Harris HK; Nakayama T; Lai J; Zhao B; Argyrou N; Gubbels CS; Soucy A; Genetti CA; Suslovitch V; Rodan LH; Tiller GE; Lesca G; Gripp KW; Asadollahi R; Hamosh A; Applegate CD; Turnpenny PD; Simon MEH; Volker-Touw CML; Gassen KLIV; Binsbergen EV; Pfundt R; Gardeitchik T; Vries BBA; Immken LL; Buchanan C; Willing M; Toler TL; Fassi E; Baker L; Vansenne F; Wang X; Ambrus JL; Fannemel M; Posey JE; Agolini E; Novelli A; Rauch A; Boonsawat P; Fagerberg CR; Larsen MJ; Kibaek M; Labalme A; Poisson A; Payne KK; Walsh LE; Aldinger KA; Balciuniene J; Skraban C; Gray C; Murrell J; Bupp CP; Pascolini G; Grammatico P; Broly M; Küry S; Nizon M; Rasool IG; Zahoor MY; Kraus C; Reis A; Iqbal M; Uguen K; Audebert-Bellanger S; Ferec C; Redon S; Baker J; Wu Y; Zampino G; Syrbe S; Brosse I; Jamra RA; Dobyns WB; Cohen LL; Blomhoff A; Mignot C; Keren B; Courtin T; Agrawal PB; Beggs AH; Yu TW
Genet Med; 2021 Jun; 23(6):1028-1040. PubMed ID: 33658631
[TBL] [Abstract][Full Text] [Related]
35. Expanding the neurological and behavioral phenotype of White-Sutton syndrome: a case report.
Donnarumma B; Riccio MP; Terrone G; Palma M; Strisciuglio P; Scala I
Ital J Pediatr; 2021 Jul; 47(1):148. PubMed ID: 34215294
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and Safety of Q10 Ubiquinol With Vitamins B and E in Neurodevelopmental Disorders: A Retrospective Chart Review.
Cucinotta F; Ricciardello A; Turriziani L; Mancini A; Keller R; Sacco R; Persico AM
Front Psychiatry; 2022; 13():829516. PubMed ID: 35308885
[TBL] [Abstract][Full Text] [Related]
37. Genomic organization of human DLG4, the gene encoding postsynaptic density 95.
Stathakis DG; Udar N; Sandgren O; Andreasson S; Bryant PJ; Small K; Forsman-Semb K
J Neurochem; 1999 Dec; 73(6):2250-65. PubMed ID: 10582582
[TBL] [Abstract][Full Text] [Related]
38. De novo nonsense and frameshift variants of TCF20 in individuals with intellectual disability and postnatal overgrowth.
Schäfgen J; Cremer K; Becker J; Wieland T; Zink AM; Kim S; Windheuser IC; Kreiß M; Aretz S; Strom TM; Wieczorek D; Engels H
Eur J Hum Genet; 2016 Dec; 24(12):1739-1745. PubMed ID: 27436265
[TBL] [Abstract][Full Text] [Related]
39. A de novo frameshift variant of ANKRD11 (c.1366_1367dup) in a Chinese patient with KBG syndrome.
Chen J; Xia Z; Zhou Y; Ma X; Wang X; Guo Q
BMC Med Genomics; 2021 Mar; 14(1):68. PubMed ID: 33653342
[TBL] [Abstract][Full Text] [Related]
40. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
